Results

Total Results: 2,078 records

Showing results for "drugs".

241. Research on Optimal Second-Line Therapy for Hypertension | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hypertension-therapy/abstract
     January 01, 2005 - is generally associated with reduced morbidity and mortality, although this is not uniform for all drugs

242. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … of tophi and kidney stones.12 Therapy for acute flares consists of nonsteroidal anti- inflammatory drugs

243. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - Tarrytown (NY): Regeneron Pharmaceuticals, Inc.; [accessed 2011 Aug 10]. [1 p]. … Tarrytown (NY): Regeneron Pharmaceuticals; 2009 Jun 11 [accessed 2011 May 23]. [2 p]. … Drugs Today 2009;45(6):423-430. … In: 29th Annual Healthcare Conference; Regeneron Pharmaceuticals, Inc; 2011 Jan 10. … Drugs R D 2008;9(3):197-202. PMID: 18457473 82. Ratner M.

244. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

245. Fifth Journal Supplement on Research Methods: Patient-Centered Health Outcomes in Rare Diseases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rare-diseases-outcomes/executive
     July 24, 2014 - Application of a Policy Framework for the Public Funding of Drugs for Rare Diseases Winquist E, Coyle … Application of a Policy Framework for the Public Funding of Drugs for Rare Diseases.

246. Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer's-Type Dementia | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cognitive-decline/research-2017
     March 24, 2017 - therapy, vitamins, antihypertensive treatment, lipid lowering treatment, nonsteroidal anti-inflammatory drugs … (NSAIDs), antidementia drugs, diabetes treatment, and "other interventions."

247. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
     October 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … It is also available as the branded drug Ketalar from JHP Pharmaceuticals, LLC, of Parsippany, NJ. … CNS Drugs. 2012 Mar 1;26(3):189-204. … Rochester (MI): JHP Pharmaceuticals, LLC; 2011 Jun. 4 p. … Available: http://www.accessdata.fda.gov/scripts/cder/drugs atfda/index.cfm?

248. Horizon Scanning Protocol and Operations Manual January 2013 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
     August 01, 2013 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Questions considered about drugs, biologics, and devices 1. … If so, do not select, because these are “me-too” of existing drugs. … Covers future industry trends, key industry developments, research and development of drugs and pharmaceuticals … Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics

249. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Curr Opin Investig Drugs. 2001 Apr;2(4):505-9. PMID: 11566007 6. Tappenden K, Edelman J. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec 01 [accessed 2013 Jun 05]. [19 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec 21. 45 p. 14.

250. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Safety of antiobesity drugs. Ther Adv Drug Saf. 2013;4(4):171-81. … Anti- obesity drugs: Past, present and future. Dis Model Mech. 2012 Sep;5(5):621-6.

251. Management of Primary Headache During Pregnancy: Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
     March 23, 2019 - For example, nonsteroidal anti- inflammatory drugs (NSAIDs) have been shown to be associated with a higher … therapies used outside of pregnancy, such as complementary and alternative therapies and biologic drugs … Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. … https://www.fda.gov/drugs/drugsafety/ucm350684.htm. Accessed on March 23, 2019. … https://www.fda.gov/drugs/drugsafety/ucm350684.htm 19 16. Andrade C.

252. Comparative Safety of NSAIDs with Gastroprotective Therapy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/nsaids-gastroprotective-therapy/research
     December 02, 2009 - strategies to reduce the risk of serious gastropathy caused by traditional nonsteroidal anti-inflammatory drugs

253. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for first-line therapy to treat AS pain. … Novartis Pharmaceuticals. 16 week efficacy and 2 year long term safety and efficacy of secukinumab … Novartis Pharmaceuticals. 16 week efficacy and 5 year long term efficacy, safety and tolerability

254. Newer Medications for Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/prostatic-hyperplasia-medications/research-protocol
     April 24, 2015 - Prescribing behavior has changed with the approval of new drugs and the availability of new evidence … for efficacy, comparative effectiveness, and harms. 6 Table 1 provides a list of drugs commonly used … and enlarged prostates with either agent are supported by systematic reviews. 10,13 Recently, newer drugs … A new AB, silodosin, was approved for the treatment of BPH in 2008. 7 Several anticholinergics drugs … symptoms such as urgency, frequency, and nocturia, which may or may not be causally related. 15 These drugs

255. Alcohol-Misuse-Drug-Therapy Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
     January 27, 2012 - The following designs were also eligible for KQ 3 if they compared two or more drugs of interest: nonrandomized … cohort studies, and case-control studies were eligible as long as the studies compared two or more drugs … J Stud Alcohol Drugs. 2008 Jul;69(4):535-8. PMID: 18612569. 19. … J Stud Alcohol Drugs. 2009 Mar;70(2):186-96. PMID: 19261230. 47. … Chronic care management for dependence on alcohol and other drugs: the AHEAD randomized trial.

256. Migraine-Emergency Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_executive.pdf
     November 01, 2012 - ergot derivatives (e.g., dihydroergotamine [DHE]), intravenous (IV) nonsteroidal anti-inflammatory drugs … Food and Drug Administration documents related to the drugs of interest were reviewed for additional … We recognize that many drugs have various effects. … For the mixed-treatment analysis, we identified a group of drugs that were not easily classified and … We refer to these drugs collectively as “orphan agents.”

257. Drug Safety | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/drug-safety

258. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
     October 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … interventions expected to be within 0 to 4 years of potential diffusion (e.g., in phase III trials for pharmaceuticals … study for use in the treatment of bipolar depression. 25 The drug was originally launched by King Pharmaceuticals … Drugs Future 2009;34(3):217-21. 25. Thomson Reuters Integrity [database online]. … J Psychoactive Drugs 2008 Sep;40(3):225-36. PMID: 19004414 54.

259. Alcohol-misuse-drug-therapy-140326 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
     January 27, 2012 - prevention or pharmacotherapy combined with various co-interventions (including both FDA-approved drugs … Inpatient settings Interventions As defined above in PICOTS Pharmacotherapy for alcohol withdrawal; any drugs … J Stud Alcohol Drugs. 2008 Jul;69(4):535-8. PMID: 18612569. 23.

260. Disruptive-Behavior-Disorder Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorder_executive.pdf
     October 01, 2015 - No studies were of drugs with an FDA indication for DBD. … to aggression), and a group of drugs comprising both stimulants and nonstimulants (typically used … Interventions included antipsychotic drugs, an antiepileptic drug, and ADHD drugs (both stimulants … The use of antiepileptic drugs (AEDs) for the treatment of pediatric aggression and mood disorders. … Pharmaceuticals. 2010;3(9):2986-3004.